Progyny Inc PGNY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PGNY is a good fit for your portfolio.
News
-
The Broken Brown Egg and Progyny Announce the 2024 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building
-
Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report
-
Progyny, Inc. to Host 2024 Inaugural Investor Day
-
Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl
-
New Survey from Progyny Shows Strong LGBTQ+ Demand for Inclusive Family Building Benefits
-
Fertility Pioneer and Kindbody Founder Gina Bartasi Returns as CEO to Lead Company's Next Phase of Growth
-
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
-
Progyny's board approves another $100 million stock buyback
Trading Information
- Previous Close Price
- $28.60
- Day Range
- $28.74–29.29
- 52-Week Range
- $23.90–44.95
- Bid/Ask
- $28.96 / $29.14
- Market Cap
- $2.77 Bil
- Volume/Avg
- 611,783 / 1.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 35.38
- Price/Sales
- 2.65
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 566
- Website
- https://www.progyny.com
Comparables
Valuation
|
Metric
|
PGNY
|
SPOK
|
ACCD
|
|---|---|---|---|
Price/Earnings (Normalized) | 35.38 | 20.31 | — |
Price/Book Value | 4.90 | 1.97 | 0.74 |
Price/Sales | 2.65 | 2.28 | 0.72 |
Price/Cash Flow | 14.23 | 10.45 | 22.20 |
Price/Earnings
PGNY
SPOK
ACCD
Financial Strength
|
Metric
|
PGNY
|
SPOK
|
ACCD
|
|---|---|---|---|
Quick Ratio | 3.25 | 1.08 | 2.62 |
Current Ratio | 3.31 | 1.30 | 2.80 |
Interest Coverage | — | — | — |
Quick Ratio
PGNY
SPOK
ACCD
Profitability
|
Metric
|
PGNY
|
SPOK
|
ACCD
|
|---|---|---|---|
Return on Assets (Normalized) | 23.41% | 8.95% | −4.92% |
Return on Equity (Normalized) | 33.33% | 12.31% | −9.07% |
Return on Invested Capital (Normalized) | 31.71% | 11.02% | −6.37% |
Return on Assets
PGNY
SPOK
ACCD
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock
GEHC
| Dttpzqj | Yvmj | $36.7 Bil | |||
| Veeva Systems Inc Class A
VEEV
| Lhnfrcxw | Tnhnd | $31.1 Bil | |||
| Solventum Corp
SOLV
| — | Ssbcv | $10.0 Bil | |||
| Pro Medicus Ltd
PMCUF
| — | Pnqckp | $9.2 Bil | |||
| HealthEquity Inc
HQY
| — | Vxppg | $7.0 Bil | |||
| Tempus AI Inc Class A common stock
TEM
| — | Rmtk | $6.9 Bil | |||
| M3 Inc
MTHRF
| — | Tmmsbf | $6.6 Bil | |||
| M3 Inc ADR
MTHRY
| — | Bxkbmn | $6.6 Bil | |||
| R1 RCM Inc
RCM
| — | Shgmd | $5.5 Bil | |||
| Doximity Inc Class A
DOCS
| — | Vyvxmpg | $5.2 Bil |